Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)

Clinical trial NCT00372892 · COMPLETED

Trial details

NCT number: NCT00372892
Sponsor: Hamilton Health Sciences Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2006-09-01
Primary completion: 2010-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.